The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac

Osama I I Soliman1, Bas M van Dalen, Dominic A M J Theuns

  • 1Thoraxcenter, Erasmus Medical Center, 3015 CE, Rotterdam, The Netherlands.

Insights

Diabetes mellitus (DM) and ischemic heart failure (HF) etiology predict poor reverse volumetric left ventricular (LV) remodeling after cardiac resynchronization therapy (CRT). Ischemic etiology is the sole independent predictor of suboptimal LV remodeling post-CRT.

Area of Science:

  • Cardiology
  • Medical Technology
  • Heart Failure Research

Background:

  • Cardiac resynchronization therapy (CRT) is a treatment for heart failure (HF).
  • Left ventricular (LV) remodeling is a key factor in HF progression.
  • The impact of diabetes mellitus (DM) on CRT outcomes requires further investigation.

Purpose of the Study:

  • To compare reverse volumetric LV remodeling after CRT in HF patients with and without DM.
  • To identify predictors of poor echocardiographic response to CRT.

Main Methods:

  • 130 HF patients undergoing CRT were analyzed.
  • Echocardiography, including tissue Doppler, was performed pre- and post-CRT.
  • Reverse volumetric LV remodeling was defined as >15% reduction in LV end-systolic volume (ESV).

Main Results:

  • Patients with DM had higher rates of hypertension and ischemic HF etiology.
  • DM patients showed less improvement in LV ESV and other diastolic function parameters post-CRT.
  • Ischemic HF etiology was the only independent predictor of poor reverse volumetric LV remodeling (HR, 2.119; P=.018).

Conclusions:

  • Ischemic HF etiology independently predicts poor echocardiographic response to CRT.
  • HF patients with DM exhibit poorer CRT response, likely due to a higher prevalence of ischemic etiology.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...